The Medical Nutrition Market consists of nutritional products specially formulated to manage and treat medical conditions and diseases. These products are prescribed to fulfill the additional nutritional requirements of patients to help support physical and mental health. The increasing prevalence of lifestyle diseases like diabetes, obesity, cancer and cardiovascular diseases globally has fueled the demand for medical nutritional products to manage co-morbidities and aid recovery process. These products offer individuals appropriate nutrients through oral consumption like liquid supplements, powders or capsules for conditions requiring a clinically proven dietary regime under medical supervision.
The Global Medical Nutrition Market is estimated to be valued at US$ 13.91 Bn in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the Medical Nutrition Market are Abbott, Danone S.A., Baxter, Nestl;, GSK plc., Sun Pharmaceutical Industries Ltd., Sanofi, DSM, BASF SE, Fresenius SE and Co. KGaA, Leprino Foods Company, Fresenius Kabi Ltd, Esperer Onco Nutrition, Kate Farms, and Guardion Health Sciences, Inc. These leading players are investing aggressively in expanding their product portfolio and manufacturing facilities globally to strengthen market presence.
The key opportunities in the Medical Nutrition Market Demand include rising demand for customized clinical nutrition and sport nutrition products. Several small and mid-sized companies are focusing on developing science-backed consumer-oriented products for improved immunity, gut health, weight management to cater to lifestyle needs.
Globally, the demand for medical nutrition is growing exponentially across North America, Europe, Asia Pacific and Latin America led by increasing research funding for clinical trials, growing awareness about nutrition-based therapies, rising geriatric population and preference for affordable orally-administered supplements. Key players are entering emerging markets through collaborations with local distributors to leverage the high-growth potential.
Market Drivers:
- Increasing prevalence of chronic diseases globally requiring medical nutrition is a key driver. Conditions like cancer, gastrointestinal disorders, diabetes, neurological disorders have elevated the need for specialized clinical feeding formulas.
- Rising healthcare spending on nutrition-based therapies for treatment and management of complicated health conditions is boosting the market growth. Several governments are supporting recommendations of medical nutrition in national clinical practice guidelines.
Market Restrain:
- High costs associated with customized nutrition and therapeutics linked to small target patient pools restrain wider market adoption. Reimbursement issues especially in developing regions pose challenges.
- Lack of awareness about the availability of varied medically-tailored nutritional products and solutions in remote areas limit the market potential particularly for preventive supplements.
Segment Analysis
In the medical nutrition market, the dominant sub-segment is the paediatric nutrition segment. This sub-segment accounts for over 35% of market share owing to the rising prevalence of nutrition and digestive diseases among infants and children. The other major segments include adult nutrition, which sees the highest growth in individuals with cancer or HIV/AIDS. The elderly nutrition segment captures over 20% share due to growing geriatric population worldwide and subsequent rise in chronic diseases like diabetes.
Global Analysis
Regionally, North America commands the largest share in the Medical Nutrition Market Regional Analysis currently. This can be attributed to high awareness levels, presence of leading companies, and significant healthcare spending. Moreover, Asia Pacific is identified as the fastest growing regional market with a CAGR of around 7% during the forecast period. This growth trajectory stems from the expanding patient population, increasing healthcare expenditures, and rising focus on preventive care in countries like China and India. On the other hand, Europe holds the second position fueled by government support and progressive research environment.
Choose preferred language for better understanding-
About Author-
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
Comments
0 comment